IP Verse

Antibodies Against Cd38 For Treatment Of Multiple Myeloma - EP3312196

PATENT ANALYSIS

Patent Details

Grant Date
Jul 17, 2019
Company
GENMAB A/S
Oppositions

SECERNA LLP

More patents of Genmab A/S

EP2943507

EP3312196

EP2535355

Want to monitor this patent?

Feel free to send us a message here and we will get back to you